Neogen Corporation Cash and Cash Equivalents, Period Increase (Decrease)
Neogen Corporation (NEOG) reported Cash and Cash Equivalents, Period Increase (Decrease) of $24.58 million for the 12-month period ending 2020-05-31, per its 10-K filed 2020-07-30.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2020-07-30
- Neogen Corporation cash and cash equivalents, period increase (decrease) for the quarter ending 2019-11-30 was $10.13M, a 132.22% increase year-over-year.
- Neogen Corporation cash and cash equivalents, period increase (decrease) for the quarter ending 2019-08-31 was $14.60M, a 3.18% increase year-over-year.
- Neogen Corporation cash and cash equivalents, period increase (decrease) for the quarter ending 2019-05-31 was -$51.89M, a 5247.62% decline year-over-year.
- Neogen Corporation cash and cash equivalents, period increase (decrease) for the quarter ending 2019-02-28 was -$8.01M, a 145.40% decline year-over-year.
- Neogen Corporation cash and cash equivalents, period increase (decrease) for fiscal 2020 was $24.58M.
- Neogen Corporation cash and cash equivalents, period increase (decrease) for fiscal 2019 was -$41.39M, a 851.52% decline from fiscal 2018.
- Neogen Corporation cash and cash equivalents, period increase (decrease) for fiscal 2018 was $5.51M, a 75.32% decline from fiscal 2017.
- Neogen Corporation cash and cash equivalents, period increase (decrease) for fiscal 2017 was $22.31M.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month |
|---|---|---|---|---|
| 2020-05-31 | $24.58M 10-K · filed 2020-07-30 | |||
| 2019-11-30 | $10.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-12-27 | $24.73M 10-Q · filed 2019-12-27 | -$27.16M derived: sum of 3 quarters · filed 2020-07-30 | -$35.17M derived: sum of 4 quarters · filed 2020-07-30 |
| 2019-08-31 | $14.60M 10-Q · filed 2019-09-26 | -$37.29M derived: sum of 2 quarters · filed 2020-07-30 | -$45.30M derived: sum of 3 quarters · filed 2020-07-30 | -$40.94M derived: sum of 4 quarters · filed 2020-07-30 |
| 2019-05-31 | -$51.89M derived: 10-K 12 month − 10-Q 9 month · filed 2020-07-30 | -$59.90M derived: sum of 2 quarters · filed 2020-07-30 | -$55.54M derived: sum of 3 quarters · filed 2020-07-30 | -$41.39M 10-K · filed 2020-07-30 |
| 2019-02-28 | -$8.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-03-29 | -$3.65M derived: sum of 2 quarters · filed 2019-12-27 | $10.50M 10-Q · filed 2019-03-29 | $11.51M derived: sum of 4 quarters · filed 2020-07-30 |
| 2018-11-30 | $4.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-12-27 | $18.51M 10-Q · filed 2019-12-27 | $19.52M derived: sum of 3 quarters · filed 2020-07-30 | $37.16M derived: sum of 4 quarters · filed 2020-07-30 |
| 2018-08-31 | $14.15M 10-Q · filed 2019-09-26 | $15.16M derived: sum of 2 quarters · filed 2020-07-30 | $32.80M derived: sum of 3 quarters · filed 2020-07-30 | $38.77M derived: sum of 4 quarters · filed 2020-07-30 |
| 2018-05-31 | $1.01M derived: 10-K 12 month − 10-Q 9 month · filed 2020-07-30 | $18.65M derived: sum of 2 quarters · filed 2020-07-30 | $24.62M derived: sum of 3 quarters · filed 2020-07-30 | $5.51M 10-K · filed 2020-07-30 |
| 2018-02-28 | $17.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-03-29 | $23.61M derived: sum of 2 quarters · filed 2019-03-29 | $4.50M 10-Q · filed 2019-03-29 | $22.18M derived: sum of 4 quarters · filed 2019-07-30 |
| 2017-11-30 | $5.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-12-28 | -$13.14M 10-Q · filed 2018-12-28 | $4.54M derived: sum of 3 quarters · filed 2019-07-30 | -$21.87M derived: sum of 4 quarters · filed 2019-07-30 |
| 2017-08-31 | -$19.11M 10-Q · filed 2018-10-05 | -$1.43M derived: sum of 2 quarters · filed 2019-07-30 | -$27.84M derived: sum of 3 quarters · filed 2019-07-30 | -$17.73M derived: sum of 4 quarters · filed 2019-07-30 |
| 2017-05-31 | $17.68M derived: 10-K 12 month − 10-Q 9 month · filed 2019-07-30 | -$8.73M derived: sum of 2 quarters · filed 2019-07-30 | $1.38M derived: sum of 3 quarters · filed 2019-07-30 | $22.31M 10-K · filed 2019-07-30 |
| 2017-02-28 | -$26.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-03-29 | -$16.30M derived: sum of 2 quarters · filed 2018-03-29 | $4.63M 10-Q · filed 2018-03-29 | -$6.98M derived: sum of 4 quarters · filed 2018-07-27 |
| 2016-11-30 | $10.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-01-05 | $31.04M 10-Q · filed 2018-01-05 | $19.43M derived: sum of 3 quarters · filed 2018-07-27 | $14.92M derived: sum of 4 quarters · filed 2018-07-27 |
| 2016-08-31 | $20.93M 10-Q · filed 2017-09-29 | $9.32M derived: sum of 2 quarters · filed 2018-07-27 | $4.81M derived: sum of 3 quarters · filed 2018-07-27 | $33.86M derived: sum of 4 quarters · filed 2018-07-27 |
| 2016-05-31 | -$11.61M derived: 10-K 12 month − 10-Q 9 month · filed 2018-07-27 | -$16.12M derived: sum of 2 quarters · filed 2018-07-27 | $12.93M derived: sum of 3 quarters · filed 2018-07-27 | -$10.80M 10-K · filed 2018-07-27 |
| 2016-02-29 | -$4.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-03-31 | $24.54M derived: sum of 2 quarters · filed 2017-03-31 | $801.00K 10-Q · filed 2017-03-31 | $9.38M derived: sum of 4 quarters · filed 2017-07-28 |
| 2015-11-30 | $29.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-12-29 | $5.32M 10-Q · filed 2016-12-29 | $13.89M derived: sum of 3 quarters · filed 2017-07-28 | $22.32M derived: sum of 4 quarters · filed 2017-07-28 |
| 2015-08-31 | -$23.73M 10-Q · filed 2016-09-30 | -$15.16M derived: sum of 2 quarters · filed 2017-07-28 | -$6.73M derived: sum of 3 quarters · filed 2017-07-28 | -$11.13M derived: sum of 4 quarters · filed 2017-07-28 |
| 2015-05-31 | $8.58M derived: 10-K 12 month − 10-Q 9 month · filed 2017-07-28 | $17.00M derived: sum of 2 quarters · filed 2017-07-28 | $12.60M derived: sum of 3 quarters · filed 2017-07-28 | $25.39M 10-K · filed 2017-07-28 |
| 2015-02-28 | $8.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-03-31 | $4.03M derived: sum of 2 quarters · filed 2016-03-31 | $16.81M 10-Q · filed 2016-03-31 | $14.21M derived: sum of 4 quarters · filed 2016-07-29 |
| 2014-11-30 | -$4.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-01-08 | $8.38M 10-Q · filed 2016-01-08 | $5.78M derived: sum of 3 quarters · filed 2016-07-29 | $5.45M derived: sum of 4 quarters · filed 2016-07-29 |
| 2014-08-31 | $12.78M 10-Q · filed 2015-09-30 | $10.18M derived: sum of 2 quarters · filed 2016-07-29 | $9.84M derived: sum of 3 quarters · filed 2016-07-29 | $9.85M derived: sum of 4 quarters · filed 2016-07-29 |
| 2014-05-31 | -$2.60M derived: 10-K 12 month − 10-Q 9 month · filed 2016-07-29 | -$2.94M derived: sum of 2 quarters · filed 2016-07-29 | -$2.93M derived: sum of 3 quarters · filed 2016-07-29 | -$9.36M 10-K · filed 2016-07-29 |
| 2014-02-28 | -$337.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-04-01 | -$332.00K derived: sum of 2 quarters · filed 2015-04-01 | -$6.76M 10-Q · filed 2015-04-01 | -$5.58M derived: sum of 4 quarters · filed 2015-07-30 |
| 2013-11-30 | $5.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-12-30 | -$6.42M 10-Q · filed 2014-12-30 | -$5.25M derived: sum of 3 quarters · filed 2015-07-30 | $2.30M derived: sum of 4 quarters · filed 2015-07-30 |
| 2013-08-31 | -$6.42M 10-Q · filed 2014-09-30 | -$5.25M derived: sum of 2 quarters · filed 2015-07-30 | $2.30M derived: sum of 3 quarters · filed 2015-07-30 | -$877.00K derived: sum of 4 quarters · filed 2015-07-30 |
| 2013-05-31 | $1.17M derived: 10-K 12 month − 10-Q 9 month · filed 2015-07-30 | $8.72M derived: sum of 2 quarters · filed 2015-07-30 | $5.55M derived: sum of 3 quarters · filed 2015-07-30 | $987.00K 10-K · filed 2015-07-30 |
| 2013-02-28 | $7.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-04-04 | $4.38M derived: sum of 2 quarters · filed 2014-04-04 | -$184.00K 10-Q · filed 2014-04-04 | $6.16M derived: sum of 4 quarters · filed 2014-07-30 |
| 2012-11-30 | -$3.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-01-09 | -$7.74M 10-Q · filed 2014-01-09 | -$1.39M derived: sum of 3 quarters · filed 2014-07-30 | $4.34M derived: sum of 4 quarters · filed 2014-07-30 |
| 2012-08-31 | -$4.56M 10-Q · filed 2013-09-30 | $1.79M derived: sum of 2 quarters · filed 2014-07-30 | $7.51M derived: sum of 3 quarters · filed 2014-07-30 | $22.45M derived: sum of 4 quarters · filed 2014-07-30 |
| 2012-05-31 | $6.35M derived: 10-K 12 month − 10-Q 9 month · filed 2014-07-30 | $12.07M derived: sum of 2 quarters · filed 2014-07-30 | $27.01M derived: sum of 3 quarters · filed 2014-07-30 | $13.20M 10-K · filed 2014-07-30 |
| 2012-02-29 | $5.73M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-03-28 | $20.67M derived: sum of 2 quarters · filed 2013-03-28 | $6.85M 10-Q · filed 2013-03-28 | $12.51M derived: sum of 4 quarters · filed 2013-07-30 |
| 2011-11-30 | $14.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-12-28 | $1.13M 10-Q · filed 2012-12-28 | $6.79M derived: sum of 3 quarters · filed 2013-07-30 | $9.89M derived: sum of 4 quarters · filed 2013-07-30 |
| 2011-08-31 | -$13.81M 10-Q · filed 2012-09-28 | -$8.15M derived: sum of 2 quarters · filed 2013-07-30 | -$5.05M derived: sum of 3 quarters · filed 2013-07-30 | -$724.00K derived: sum of 4 quarters · filed 2013-07-30 |
| 2011-05-31 | $5.66M derived: 10-K 12 month − 10-Q 9 month · filed 2013-07-30 | $8.76M derived: sum of 2 quarters · filed 2013-07-30 | $13.09M derived: sum of 3 quarters · filed 2013-07-30 | $13.04M 10-K · filed 2013-07-30 |
| 2011-02-28 | $3.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-03-30 | $7.43M derived: sum of 2 quarters · filed 2012-03-30 | $7.38M 10-Q · filed 2012-03-30 | |
| 2010-11-30 | $4.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-12-30 | $4.28M 10-Q · filed 2011-12-30 | ||
| 2010-08-31 | -$50.00K 10-Q · filed 2011-09-30 | |||
| 2010-05-31 | $8.96M 10-K · filed 2012-07-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |